Comparison of four cycles epirubicin and cyclophosphamide (EC) followed by four cycles docetaxel (T) versus six cycles docetaxel and carboplatin (TP) as adjuvant chemotherapy for women with operable triple negative breast cancer. | |
Yuan, Peng; Du, Feng; Wang, Jiayu; Ma, Fei; Fan, Ying; Xu, Binghe | |
2016 | |
会议名称 | JOURNAL OF CLINICAL ONCOLOGY |
会议日期 | 2016-05-20 |
收录类别 | CPCI-S |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6384867 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Yuan, Peng,Du, Feng,Wang, Jiayu,et al. Comparison of four cycles epirubicin and cyclophosphamide (EC) followed by four cycles docetaxel (T) versus six cycles docetaxel and carboplatin (TP) as adjuvant chemotherapy for women with operable triple negative breast cancer.[C]. 见:JOURNAL OF CLINICAL ONCOLOGY. 2016-05-20. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论